Resources

Around one in seven couples can expect to struggle with infertility, with myriad causes from polycystic ovary syndrome (PCOS) to low sperm count. Many couples who are struggling to conceive will try and estimate the female partner’s ovulatory window in order to...

Admedus, an Australia-based company, announced the sale of distribution rights to its CardioCel and VascuCel businesses to LeMaitre Vascular in October for up to A$36.2m (US$24.7m). Admedus’ products are based around its proprietary ADAPT tissue technology,...

UK-based CMR Surgical has announced that Galaxy Care Hospital in Pune, India has become the first facility in the world to purchase the Versius minimal access surgery (MAS) system. Galaxy Care is a specialist hospital in laparoscopic surgery, and a range of surgeries...

ArsenalBio has exited stealth with $85 million to discover and develop cell therapies. The biotech aims to differentiate itself from the ever-growing pack of cell therapy startups with technology that enables the insertion of large DNA sequences without the use of...

A clinical trial principally funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has found an artificial pancreas system could effectively control blood glucose levels in patients with type 1 diabetes. The closed-loop system,...

Researchers at Ecole polytechnique fédérale de Lausanne (EPFL)’s Laboratory for Soft BioElectronic Interface (LSBI) are developing a conformable, electrode implant to restore hearing in those with a dysfunctional inner ear. The implant will provide...

A clinical trial of an artificial pancreas system showed it was able to outperform current treatments for people with Type 1 diabetes and help maintain blood sugar levels throughout the day as well as overnight.

By studying star-shaped cells in the brain called astrocytes, scientists at the University of California, Los Angeles identified a strategy that might halt or reverse Huntington’s disease—and may even help research into other neurodegenerative diseases.

Sandoz is pulling the plug on its commercialization partnership with Pear Therapeutics, ending its experiment with digital treatments for substance use disorders that first kicked off in April 2018.

MedImmune’s vice president of research and head of oncology R&D Ronald Herbst, Ph.D., has followed a series of other AstraZeneca and its biologics arm staffers out the door.

Due to meetings in London on a Friday and in Dortmund on the following Monday, I spent the weekend in London.  As I walked the streets appreciating its history, I could not help but think of the history of medicine, as well.  Images of leeches and...

Building a leading gene therapy pipeline in under two years (and a lot of air miles): how to persevere and make the calls that matter. Throughout a career in business development I’ve sat at every seat at the negotiating table, but I count my experience building...

Nearly two years ago, Nessan Bermingham, Ph.D., handed the reins of Intellia Therapeutics over to John Leonard, M.D., the R&D chief who had built the company alongside him. After a break, he landed at Atlas Venture, the VC firm that helped launch...

The scientific founder and CEO of Cambridge startup Dyne Therapeutics has hired a new CEO — a former CFO with experience in public stock offerings. Read more. The post With eyes on IPO, muscular dystrophy startup names new CEO appeared first on Atlas Venture.

“Time flies when you’re having fun.” That’s how I feel as I reflect on the first three years of the growth of Kyn Therapeutics. So much has happened since my R&D colleague Michelle Zhang and I moved into the seed space at Atlas Venture (see...

Texas Instruments rolled out a new battery charger IC that boosts the run time of compact consumer and medical electronics while cutting charging times and filling up more of the battery's available capacity. The new switching battery

Machine Design visits Columbus, Ohio to follow up on how the city using its winning grant money to make it an innovative place to live, learn, and labor.

Learn how these technological innovations helped users to regain lost function.

Commonly Reprocessed Medical Devices The post Commonly Reprocessed Devices, AMDR Overview appeared first on AMDR.

Marktech’s range of silicon photodiodes includes additional processes, active area sizes, case isolation, and packaging options.

Just five months after Novartis put down $310 million for IFM Therapeutics’ inflammation-focused unit, the Big Pharma has come back for more. This time, it is teaming up with IFM Due, the subsidiary IFM created to develop treatments targeting the cGAS...

One of the joys of building a company is that meeting one’s milestones routinely places us in positions that are new, where past experience may not be a guide.  Our ability to navigate growth is highly dependent on building a team that’s ready to take...

Suppliers must prepare for new robots with new needs.

The Association of Medical Device Reprocessors urged the European Commission to delete provisions of Article 5 of its specifications for reprocessing single-use medical devices because of a lack of legal basis for placing obligations on device makers, and to make...

AMDR Response to Stakeholder Comments The European Union is moving closer to fully implementing its requirements for single-use device (SUD) reprocessing and remanufacturing as part of the new comprehensive European Medical Device Regulation.  On August 20, the...